Who
Jonathan Adam Feldschuh
Chief Scientific Officer
Company insider
Files Form 4 as: Chief Scientific Officer, Daxor.
In numbers
- Trades disclosed
- 7
- Buys
- 2
- Sells
- 1
- Bought
- $0
- Sold
- $358K
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 15 Mar 2018
- Last trade
- 23 Jun 2026
- Last filed
- 25 Jun 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 23 Jun 2026filed 25 Jun 2026 | DXR DaxorMedical Devices | SEC FORM 4 Code A | —25,000 at $0.00 | filing |
| 23 Jun 2026filed 25 Jun 2026 | DXR DaxorMedical Devices | SEC FORM 4 Code A | —25,000 at $0.00 | filing |
| 9 Dec 2025filed 11 Dec 2025 | DXR DaxorMedical Devices | SEC FORM 4 Bought | —18,000 at $0.00 | filing |
| 6 Dec 2024filed 10 Dec 2024 | DXR DaxorMedical Devices | SEC FORM 4 Bought | —32,000 at $0.00 | filing |
| 11 Jul 2023filed 13 Jul 2023 | DXR Daxoroption or derivative · Medical Devices | SEC FORM 4 Code A | —25,000 at $0.00 | filing |
| 25 Jun 2020filed 29 Jun 2020 | DXR Daxoroption or derivative · Medical Devices | SEC FORM 4 Code A | —20,000 at $0.00 | filing |
| 15 Mar 2018filed 19 Mar 2018 | DXR DaxorMedical Devices | SEC FORM 4 Sold | $358K19,194 at $18.63 | filing |
News
No headline names them, or the companies they trade most, lately.